Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development

Laurie Stephen of Ampersand Biosciences co-authored an article in the AAPS Journal titled, “Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.” This article features multiplex assays and their complexity, how they create many unique challenges, and the purpose of biomarker multiplex ligand binding assays in drug development.